| IRAN |
|
|
|
|
|
| Last update |
2010-02 |
2007-02 |
|
| Company |
CSL-Behring |
Kedrion |
|
| Name of
product |
Sandoglobulin
(lyo) |
IG
VENA |
|
| Available
for Hospital therapy |
Registered |
Yes |
|
| Available
for Home therapy |
- |
None |
|
| IVIG,
SCIG or IMIG |
IVIG |
IVIG |
|
| Patient´s
age |
Adults and
children |
Adults &
Children |
|
| Présentation |
Lyophilisat |
Liquid |
|
| Concentration
% |
3%, 6%, 9%, 12% |
5% |
|
| Content
of IgG |
≥ 96% |
95% |
|
| IgG1 |
60.7% |
24,3 -
37,2 mg |
|
| IgG2 |
31.9% |
12,4 -
22,1 mg |
|
| IgG3 |
3.8% |
0,9 -
1,5 mg |
|
| IgG4 |
3.6% |
0,1 -
0,5 mg |
|
| Content
of IgA |
1.2g/L (typical
value) |
< 0,05 mg/ml |
|
| Glucose,
Maltose,… |
Sucrose |
Maltose |
|
| Average
dosage for PID |
0.2-0.8g/kg
bodyweight |
0,4 - 0,8 g/kg |
|
| Max.
Speed of infusion |
About
2.5ml/min |
40 drops/minute |
|
| Intervals
of infusion for PID |
Usually every
2-4 weeks |
21-28 days |
|
| Preserving |
3 years
≤25°C |
+2C°<
T <+8C° |
|
| Time for
reconstitution |
A few minutes |
Ready for use |
|
| Packaging* |
1g, 3g, 6g, 12g |
1g/
20 ml ; 2,5 g/ 50 ml ; 5 g/ 100 ml ;
10 g/ 200 ml |
|
| * May be different from country to country |
|
|
|
|
|
|
|
|